Oct
17
Drug Safety Updates: Raptiva (efalizumab)
October 17, 2008 | Leave a Comment
From the FDA MedWatch on October 17, 2008:
FDA notified healthcare professionals of extensive labeling changes, including a Boxed Warning, to highlight the risks of life-threatening infections, including bacterial sepsis, viral meningitis, invasive fungal disease, progressive multifocal leukoencephalopathy and other opportunistic infections with the use of Raptiva. In addition, the prescribing information will be updated to describe a potential risk for the permanent suppression of the immune system with repeat administration of Raptiva in children. Raptiva is not approved for children under 18 years of age.
Doctors and other prescribers should carefully evaluate and weigh the risk/benefit profile of Raptiva for patients who would be more susceptible to these risks. Health care professionals should monitor patients treated with Raptiva for the signs and symptoms of these adverse events and also instruct patients to report any such signs and symptoms to them without delay. Patients identified to begin therapy with Raptiva should have received all their age-appropriate vaccinations before starting the drug.
Patients with pre-existing infections or who have a compromised immune system should notify their health care professional before beginning treatment with Raptiva.
Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time. The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine, or treatment.
Oct
15
New Drug: Astepro
October 15, 2008 | Leave a Comment
Active ingredient(s): Azelastine HCl
Dosage form: nasal spray
Manufacturer: Medpointe
Usage: seasonal allergic rhinitis
Approval Date: October 15, 2008
For more information visit http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Label_ApprovalHistory#apphist
Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time. The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine, or treatment.
Oct
11
Drug Coupon: Enablex
October 11, 2008 | Leave a Comment
Get a free trial of Enablex with your doctor’s prescription.
Get more details at http://www.enablex.com/info/supportResource/trial/enablex-trial-voucher.jsp?creative=100002&site=100005&source=01030&campaign=enablx
Check out our list of coupons for this drug and others at Rx $$$.
Oct
10
New First-Time Generic Drug Approvals for September
October 10, 2008 | Leave a Comment
|
Brand Name |
Generic Drug Name |
Generic Manufacturer |
Approval Date |
| Razadyne ER | Galantamine ER 8mg, 16mg, 24mg | Barr |
9/15/08
|
| Caridolite Injection | Technetium Tc 99m Sestamibi Injection | Mallinckrodt |
9/22/08 |
| Ketalar Injection | Ketamine 10mg/ml | Bioniche |
9/30/08 |
Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time. The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine, or treatment.
Oct
8
New Drug: Rapaflo
October 8, 2008 | Leave a Comment
Active ingredient(s): Silodosin 4mg and 8mg
Dosage form: capsules
Manufacturer: Watson
Usage: treatment of symptoms due to benign prostatic hyperplasia (BPH), a condition also known as an enlarged prostate.
Approval Date: October 8, 2008
For more information visit http://www.fda.gov/bbs/topics/NEWS/2008/NEW01902.html
Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time. The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine, or treatment.
Oct
7
New Drug: Akten
October 7, 2008 | Leave a Comment
Active ingredient(s): Lidocaine HCl
Dosage form: 3.5% Ophthalmic Gel
Manufacturer: Akorn
Usage: a local anesthetic indicated for ocular surface anesthesia during ophthalmologic procedures
Approval Date: October 7, 2008
For more information visit http://www.fda.gov/cder/foi/label/2008/022221lbl.pdf
Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time. The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine, or treatment.
Oct
2
Drug Coupon: Prevacid
October 2, 2008 | Leave a Comment
Join the Beyond the Burn Program and receive up to $25 instant savings on each Prevacid prescription and refill. Program expires November 30, 2008.
Check out our list of coupons for this drug and others at Rx $$$.
